Dosing underway in Moderna's Phase 2/3 study of mRNA-1345 RSV vaccine
November 18 2021 - 6:25AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Apr 2024 to May 2024
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From May 2023 to May 2024